DataCeutics CR Toolkit(TM) Now Available Under SAS Version 9.1.3
DataCeutics, Inc. announced that the CR Toolkit(TM), DataCeutics’ SAS(R) based clinical reporting software that produces reports for regulatory submissions, has been successfully validated under SAS(R) Version 9.1.3. The validation results confirm the full compatibility of the CR Toolkit(TM) with SAS(R) Version 9.1.3.
The CR Toolkit(TM) is used by statistical programmers and statisticians to quickly and easily generate reports, tables, listings and graphs for regulatory submissions. The CR Toolkit(TM) is a comprehensive library of SAS(R) macros that automate clinical reporting to achieve process improvements resulting in time savings, operational cost reduction and better adherence to regulatory requirements. By automating page layouts for all output, the CR Toolkit(TM) can reduce workload and time by 50%, accelerating the production of tables, listings and graphs and reducing the need for validation.
Paul Gilbert, President of DataCeutics adds, “DataCeutics has an outstanding record of responsiveness to our clients’ needs and software enhancement suggestions. The CR Toolkit(TM) is a product of 10 years of collective industry experience and our collaboration with industry-leading pharmaceutical and biotech companies to develop software that helps standardize and automate the clinical reporting process. The industry is increasingly adopting SAS(R) Version 9.1.3. As clients’ needs evolve, so does the CR Toolkit(TM).”
DataCeutics, Inc. is the leading consulting company focused entirely on the life sciences industry and has been providing high quality services and innovative software solutions to the pharmaceutical, biotechnology and CRO industries for over 12 years. DataCeutics’ leading reporting products are the CR Toolkit(TM), the Clinical Reporting Solution(TM), and DataCeutics Report Portal(TM).
DataCeutics, Clinical Reporting Solution, DataCeutics Report Portal and CR Toolkit are trademarks of DataCeutics, Inc. All other trademarks and registered trademarks are the property of their respective owners.
